Korean J Gastroenterol.
2016 Feb;67(2):121-121. 10.4166/kjg.2016.67.2.121.
Corrigendum: Predictive Factors for Sustained Remission after Discontinuation of Antiviral Therapy in Patients with HBeAg-positive Chronic Hepatitis B
- Affiliations
-
- 1Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.
- 2Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
- 3Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
- 4Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.
- KMID: 2383554
- DOI: http://doi.org/10.4166/kjg.2016.67.2.121
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Predictive Factors for Sustained Remission after Discontinuation of Antiviral Therapy in Patients with HBeAg-positive Chronic Hepatitis B
- Predictive Factors and Efficacy of Lamivudine Treatment in Chronic Hepatitis B Infection
- The Effect of Lamivudine Therapy for Chronic Liver Disease due to Hepatitis B Virus Infection
- Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
- Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients
